Source BioScience LifeSciences run the DNA Sequencing facility at the Department of Biochemistry. Below is a press release from when the company was known as Geneservice Ltd.
Geneservice acquires the DNA Sequencing facility at
Biochemistry Department, University of Oxford
6 February 2007, Cambridge, UK- Geneservice Ltd, today announced that it has acquired the sequencing facility at the Biochemistry Department, University of Oxford. The aim is to create an Oxford based one-stop-shop for genomics contract research, including: DNA sample processing, genotyping, mRNA expression analysis, and microbiological clone management. In particular, the Oxford hub will provide customers throughout Oxford and neighboring regions access to more than 10 years of DNA sequencing experience, and the added benefits of online ordering, comprehensive template recovery, direct sample collection and local customer service support.
The existing DNA sequencing facility, within the Biochemistry Department will become Geneservice’s local service hub, with existing university personnel transferring to the company and Simon Mayes moving from the Cambridge operations to lead the new team. Simon will be responsible for integrating Cambridge and Oxford activities, particularly the introduction of extensive quality systems and procedures.
Tom Weaver, Geneservice’s CEO, commented “Geneservice is really happy to partner with the premier Biochemistry Department in the UK. We plan to grow the hub and its service offerings, particularly as the Department expands into new premises. The ability to work closely within the university environment is helpful since such close adjacencies allows us to provide a better local customer service and form strategic collaborations for introducing new applications and technology platforms. We also see this as the first of several similar alliances around the UK.”
On behalf of the dept of Biochemistry, Prof. David Sherratt, Chair of the DNA Sequencing Management Committee commented "Geneservice Ltd is a successful management buyout of the UK Medical Research Council in 2005. Their track record of quality contract research gives us confidence that the sequencing
service facility that we have transferred to them today will continue to prosper and provide the quality service that our scientists and all our external customers have come to expect from us. We see the opportunities of
future diversity as partners with Geneservice as a valuable opportunity for the future development of more core services for the science community in Oxford".
For more information please see www.lifesciences.sourcebioscience.com
Pictures from the 6th February are posted below (please click for a larger view):